Nigrostriatal dopaminergic neurons express many nicotinic acetylcholine receptor (nAChR) subunits capable of forming multiple nAChR subtypes. These subtypes are expressed differentially along the neuron and presumably mediate diverse responses. ␤3 subunit mRNA has restricted expression but is abundant in the substantia nigra and ventral tegmental areas. To investigate the potential role(s) of nicotinic receptors containing the ␤3 subunit in dopaminergic tracts, we generated mice with a null mutation in the ␤3 gene. We were thereby able to identify a population of ␤3-dependent ␣-conotoxin MII-binding nAChRs that modulate striatal dopamine release. Changes were also observed in locomotor activity and prepulse inhibition of acoustic startle, behaviors that are controlled, in part, by nigrostriatal and mesolimbic dopaminergic activity, respectively, suggesting that ␤3-containing nAChRs modulate these behaviors.
Introduction
Nicotinic acetylcholine receptor (nAChR) subtypes are composed of distinct combinations of subunits that exhibit unique pharmacological and physiological properties. With 11 neuronal subunits (␣2-␣7, ␣9 -␣10, and ␤2-␤4) identified in mammalian brain (Lindstrom et al., 1996; Elgoyhen et al., 2001) , the potential for subtype diversity is quite large; however, restrictions imposed by regional expression of subunit mRNAs and subunit assembly limit this diversity. In the substantia nigra of rodents, mRNA of many nAChR subunits is expressed (Marks et al., 1992; Clarke, 1993; Charpantier et al., 1998; Klink et al., 2001; Azam et al., 2002) , suggesting that the pathway projecting from the substantia nigra to striatum may possess complex populations of nAChRs. The function of these various subtypes has yet to be established definitively.
Presynaptic nAChRs mediate the release of many neurotransmitters in the brain, including dopamine from striatum (Wonnacott, 1997) . Indeed, functional, ligand-binding, immunoprecipitation, and single-cell RT-PCR experiments have uncovered a considerable number of nAChR subtypes expressed in the nigrostriatal pathway (Charpantier et al., 1998; Quik et al., 2000; Reuben et al., 2000; Tsuneki et al., 2000; Jones et al., 2001; Klink et al., 2001; Azam et al., 2002; Grady et al., 2002; Zoli et al., 2002) . Pharmacological studies indicate that striatal dopamine release is regulated by more than one nAChR subtype (Kulak et al., 1997; Kaiser et al., 1998; Nayak et al., 2001; Grady et al., 2002) . ␤3 nAChR subunit mRNA is highly expressed in dopaminergic neurons of the substantia nigra and ventral tegmental areas (Deneris et al., 1989) and can assemble into complex nAChRs (Forsayeth and Kobrin, 1997; McIntosh et al., 2000; Vailati et al., 2000; Zoli et al., 2002) , leading to the postulate that this subunit is an important component of nigrostriatal nAChRs. We investigated the significance of the ␤3 subunit in nigrostriatal nAChRs by generating mice with a null mutation in the ␤3 gene. Analysis of ␤3 null mutant mice demonstrated that a population of nAChRs containing the ␤3 subunit and sensitive to inhibition by ␣-conotoxin MII modulates striatal dopamine release. Deletion of the ␤3 subunit also altered locomotor activity, a behavior that is regulated in part by nigrostriatal dopaminergic neurotransmission, and prepulse inhibition (PPI) of acoustic startle response, which is regulated in part by mesolimbic dopaminergic transmission. These data suggest that ␤3-containing nAChRs are involved in modulating these behaviors.
Materials and Methods
Generation of ␤3 knock-out mice. Exon V of the ␤3 gene (mouse genomic clone B327) was interrupted by insertion of an internal ribosome entry site (IRES)-tau-lacZ (gene encoding ␤-galactosidase) cassette (Mombaerts et al., 1996) and a LoxP-neo r -LoxP cassette into a BclI site. Diphtheria toxin A coding fragment, from plasmid pMC1DT-3 (Yagi et al., 1993) , was engineered at the 3Ј end of the targeting construct for the negative selection. Transfection of 129Svj embryonic stem (ES) cells was performed by electroporation with the linearized targeting construct, and homologous recombination was analyzed by Southern blot. Positive ES cell colonies were injected into C57BL/6 blastocysts. Germ-line transmission was determined by Southern blot analysis of tail DNA digested with HindIII and assessed using the 3Ј probe. Although the targeted allele contained the IRES-tau-LacZ fusion, ␤-galactosidase could not be detected by conventional or enhanced staining methods, leading us to hypothesize possible problems associated with the translation of LacZ, which is initiated by ribosomal binding to the IRES. Mice were maintained at the Salk Institute and the University of Colorado, with a 12 hr light/dark cycle (6 A.M.-6 P.M.) in the vivarium and ad libitum access to food and water. All procedures were approved by the Animal Care and Utilization Committee at the Salk Institute and the University of Colorado. Mice were maintained on a 129Svj ϫ C57BL/6 background by heterozygous matings.
In situ hybridization. Coronal sections (14 m) were used for in situ hybridization with a protocol identical to that described previously (Marks et al., 1992) . Riboprobes complementary to mRNA encoding the intracellular domain of the ␤3 subunit (downstream of the IRES-tauLacZ-neo r insertion) were synthesized by in vitro transcription. The construct was linearized with BglII, and the probe was synthesized using T7 RNA polymerase. Mouse ␣3, ␣4, ␣6, ␣7, ␤2, ␤3, and ␤4 cDNA clones were also used for the in situ hybridizations. The mouse nicotinic receptor ␣7 subunit cDNA was isolated from a C57BL/6 whole-brain library as described previously (Stitzel et al., 1996) . The ␣7RR construct used for in situ hybridization contains the 5Ј-most 597 bp of the ␣7 cDNA (Stitzel et al., 1996) . The mouse nicotinic receptor ␣6 subunit cDNA was a generous gift from the laboratory of Dr. Jean-Pierre Changeux (Institut Pasteur, Paris, France). All remaining mouse nicotinic receptor subunit cDNAs were generated by PCR using either Advantage HFII DNA polymerase (Invitrogen, Carlsbad, CA) (␣4 and ␤2) or pfu DNA polymerase (Roche, Indianapolis, IN) (␣3, ␤3, and ␤4). The ␣4 (1953 bp) and ␤2 (1548 bp) cDNAs were amplified from whole-brain total RNA isolated from the long-sleep selected mouse line. The ␣3 (1612 bp), ␤3 (1546 bp), and ␤4 (1578 bp) cDNAs were amplified from DBA/2Ibg adrenal gland total RNA, long-sleep selected line ventral tegmental area total RNA, and P19 teratocarcinoma cell total RNA, respectively. Primers used for cDNA amplification were as follows: ␣3 (5Ј-GCTTAGCT-GTGCTTCGGTGGTG-3Ј, 5Ј-CTTTCATCAGCACAGGTGAGC-3Ј), ␣4 (5Ј-CCATGGAGATCGGGGGCTCCG-3Ј, 5Ј-GTGGGTGGACTGACGA-GTCGC-3Ј), ␤2 (5Ј-CTCCGCGCTATGCAGGCGGC-3Ј, 5Ј-GAGGAG-CTGCAAATGAGAGAC-3Ј), ␤3 (5Ј-CGTCTCTCTGAAGCAGACGTC-3Ј, 5Ј-GGCTCCCAGGACAAGGCAAGGGCACC-3Ј), and ␤4 (5Ј-CATTGT-GGGGTGACCGGCAGC-3Ј, 5Ј-GTGGGATGATATGAGCAGCC-3Ј).
Mouse ␣2 and ␣5 were not available, so rat clones HYP16rev and A␣5 (Marks et al., 1992) were used. Plasmids were linearized and cRNA was synthesized with the appropriate RNA polymerase. ␣-35 S-UTP was used as the sole source of UTP. Full-length transcripts were hydrolyzed to ϳ500 base length before hybridization. After wash and dehydration, slides were initially apposed to Cyclone Phosphorimaging screens (Packard). Tissue homogenate standards containing known amounts of 35 S were included on each screen to allow quantitation of signal intensity using a Cyclone Phosphorimager (Packard). Groups were compared by one-way ANOVA. Slides were then apposed to Kodak MR film to obtain photographic images.
Autoradiography. Coronal tissue sections (14 m) were collected at 1. 3-1.4 (Marks et al., 1998; Whiteaker et al., 2000b) . Saturation binding was determined using eight [
125 I]epibatidine concentrations (2-400 pM). Blanks were determined by including 100 M (Ϫ)-nicotine in the incubation. Samples (30 l final volume) were incubated at 22°C for 3 hr before filtration and washed as described previously (Whiteaker et al., 2000b) . Saturation binding data were fit to a single-site Hill equation. Inhibition of the binding of 200 pM [ 125 I]epibatidine was measured using 10 cytisine concentrations (0.1-3000 nM). Inhibition curves were fit to a two-site model as described previously (Marks et al., 1998; Whiteaker et al., 2000b) . Binding parameters were compared using a one-way ANOVA followed by Duncan's post hoc test.
Dopamine release. The perfusion method used to examine the release of [
3 H]dopamine from mouse striatal synaptosomes has been described previously (Grady et al., 2002) . Previous studies have demonstrated that under these experimental conditions, uptake of [ 3 H]dopamine occurs exclusively via the dopamine transporter in mouse striatum (Grady et al., 2002) . Experiments were conducted at room temperature with nomifensine added to the perfusion buffer (10 M) to prevent reuptake. Synaptosomes were perfused at 1 ml/min for 10 min before exposure to agonist for 18 sec. Individual animals were assayed for (Ϫ)-nicotinestimulated dopamine release at 8 (Ϫ)-nicotine concentrations.
Fifteen fractions were collected; baseline was calculated from fractions collected before and after agonist exposure. Stimulated release was calculated as a fraction of unstimulated baseline (units of release). Fractions with units of release Ͼ0.1 were summed to determine total units of release. To determine the ␣-conotoxin MII-resistant portion of dopamine release, aliquots of synaptosomes were perfused for 5 min with 50 nM ␣-conotoxin MII immediately before the 18 sec nicotine exposure. The ␣-conotoxin MII-sensitive portion of dopamine release was calculated by difference from release stimulated by nicotine from synaptosomes not treated and those treated with ␣-conotoxin MII. Each individual mouse was assayed for ␣-conotoxin MII-sensitive and -resistant dopamine release at each concentration of nicotine. EC 50 values and maximum release (R max ) were calculated from the Hill equation using a nonlinear curve-fitting algorithm and assessed for statistical significance by one-way ANOVA.
Behavioral testing. ␤3 ϩ/ϩ , ␤3 ϩ/Ϫ , and ␤3 Ϫ/Ϫ mice between 80 and 90 d of age were tested between 9 A.M. and 6 P.M. (approximately equivalent number of males and females). Locomotor activity was assessed in an illuminated open field arena (Marks et al., 1986) for 60 min. Acoustic startle as a measure of sensorimotor reactivity and prepulse inhibition of acoustic startle as a measure of sensorimotor gating (Bullock et al., 1997) were assessed in separate animals. After a 3 min acclimation period of 70 dB white noise, mice were exposed to a sequence of pure acoustic trials interspersed with PPI trials in pseudorandom order. Each sequence consisted of one acoustic trial (90, 95, 100, 105, 110, 115, or 120 dB) and one PPI trial (acoustic prepulse of 75, 80, 85, 90, or 95 dB given 120 msec before a 120 dB acoustic stimulus). Each trial was separated by an intertrial interval of 10 or 15 sec in pseudorandom order, and the entire sequence was repeated four times. The average of all four presentations of each trial was used, and a ratio of startle response with prepulse to response without prepulse was used. Results were assessed using repeated measures multiple ANOVA (MANOVA) (SPSS, Chicago, IL). Analyses were collapsed on sex because no interaction of sex with genotype was detected for any variable examined.
Results
Generation of ␤3 null mutant mice ␤3 null mutant mice were generated using homologous recombination techniques (Cappechi, 1989) to disrupt the ␤3 gene by inserting a cassette containing an internal ribosome entry site (IRES), a tau-lacZ fusion, and a neomycin resistance gene into exon V, upstream of the sequence encoding the first transmembrane domain (Fig. 1 A) . Analysis of tail DNA by Southern blot confirmed the incorporation of the targeting cassette ( Fig. 1 B) . As compared with wild-type (␤3 ϩ/ϩ ) or heterozygous (␤3 ϩ/Ϫ ) littermates, null mutant mice (␤3 Ϫ/Ϫ ) are of normal body weight, capable of reproduction, and display no gross physical or developmental deficits.
In situ hybridization
Expression of ␤3 mRNA in the brain was examined using in situ hybridization. Using a riboprobe complementary to the intracellular loop of ␤3 (encoded by exon V downstream of the gene disruption site), strong expression of ␤3 mRNA was detected in the substantia nigra, ventral tegmental area, and medial habenula, with weaker labeling in the superior colliculi and a subset of the medial vestibular nuclei of ␤3 ϩ/ϩ mice ( Fig. 2 A) , consistent with our report of the initial cloning of the ␤3 gene (Deneris et al., 1989) . Decreased expression was observed in ␤3 ϩ/Ϫ mice, whereas no specific labeling was detected in ␤3 Ϫ/Ϫ mice, verifying disruption of the ␤3 gene. Similar expression patterns were observed with a full-length mouse ␤3 cDNA (hydrolyzed) probe (Fig. 2 B) . Semiquantitative analysis of the data shown in Figure  2 B demonstrated that disruption of exon V reduced, but did not eliminate, ␤3 mRNA hybridization measured with the full-length cRNA (Fig. 2C ). This result contrasts with that obtained with the probe directed toward the disrupted sequence (see Discussion).
In situ hybridization studies were also conducted for other neuronal nAChR subunits to investigate any compensatory expression in the cell body and terminal regions of the substantia nigra and ventral tegmental area after deletion of the ␤3 subunit (Fig. 3) . No significant difference in mRNA expression was detected at the level of the dopaminergic cell bodies in substantia nigra or ventral tegmental areas for ␣3, ␣4, ␣5, ␣6, ␣7, ␤2, or ␤4 after deletion of the ␤3 subunit (␣2 mRNA levels were below the level of detection in these regions). ␣7 and ␤2 mRNA were also detected in striatum, olfactory tubercles, and nucleus accumbens (dopaminergic terminal areas). Disruption of the ␤3 gene did not affect expression of mRNA for these subunits (data not shown). ]␣-conotoxin MII (a radiolabeled derivative of a peptide originally isolated from the venom of the predatory marine snail, Conus magus) binds in discreet regions of mouse brain, including regions that are rich in dopaminergic terminals, such as striatum, olfactory tubercle, and nucleus accumbens (Whiteaker et al., 2000a) . Furthermore, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) lesions in monkeys reveal that striatal [
Ligand binding
125 I]␣-conotoxin MII-binding nAChRs are found exclusively on substantia nigra-ventral tegmental area dopaminergic projections (Quik et al., 2001 (Whiting and Lindstrom, 1988; Flores et al., 1992; Picciotto et al., 1995; Marubio et al., 1999) . At the level of the striatum, ␤3
ϩ/ϩ animals displayed intermediate levels of [ 3 H]nicotine binding in the olfactory tubercles and ventrolateral parts of the striatum and lower densities in the dorsal striatum and nucleus accumbens (Fig. 4 A, 125 I]␣-bungarotoxin binding were seen in the ventral and lateral striatum, with relatively low levels in the nucleus accumbens and olfactory tubercles (Fig. 4 A, third row, D Ϫ/Ϫ mice may reflect the difficulty of measuring this small subset (Ͻ15% of the total binding sites) (Whiteaker et al., 2000a) . Alternatively, loss of ␤3 subunits may result in an increase in other [
3 H]epibatidine-binding nAChR subtypes, or loss of ␣-conotoxin MII sensitivity in receptors previously containing the ␤3 subunit.
To test these alternative possibilities, the effect of ␤3 genotype on [
125 I]epibatidine binding was measured in striatal membrane homogenates (Fig. 5) . Saturation binding analysis (Fig. 5A) Figure 2 . Expression of ␤3 mRNA across genotypes using in situ hybridization. A, In situ hybridization conducted using an antisense riboprobe complementary to the ␤3 cytoplasmic loop (downstream of inserted IRES-tau-lacZ-neo r cassette). Specific labeling of ␤3 mRNA expression was observed in medial habenula (MH), superior colluculus (SC), and substantia nigraventral tegmental (SN/VTA) areas in ␤3 wild-type (ϩ/ϩ) mice. Slightly lower levels were observed in ␤3 heterozygous mice (ϩ/Ϫ), whereas all specific labeling was lost in ␤3 null mutants (Ϫ/Ϫ). B, In situ hybridization using a full-length mouse cDNA probe (hydrolyzed). Specific labeling of ␤3 mRNA was detected in the same regions as above. Samples from ␤3 Ϫ/Ϫ mice demonstrated reduced labeling relative to those from ␤3 ϩ/ϩ mice, but some residual labeling was retained even in ␤3 Ϫ/Ϫ samples ( C). C, Semiquantitative analysis of in situ hybridization data obtained using the full-length mouse cDNA (hydrolyzed) probe. ␤3 mRNA was reduced by ϳ70% from wild-type values in every region examined. CTX, Cortex; MH, medial habenula; OPN, olivary pretectal nucleus; DLGN, dorsolateral geniculate nuclei; VLGN, ventrolateral geniculate nuclei; SN, substantia nigra; VTA, ventral tegmental area; SC, superior colliculi; LC, locus coeruleus.
[cytisine-sensitive binding; B max ϭ 87.6 Ϯ 5.5 fmol/mg (protein), K i ϭ 0.42 Ϯ 0.03 nM; cytisine-resistant binding; B max ϭ 8.5 Ϯ 2.1 fmol/mg (protein); K i ϭ 34.7 Ϯ 17.2 nM]. Thus, ␤3 deletion results in a gene-dose-dependent loss of cytisine-resistant striatal [ 125 I]epibatidine binding sites (one-way ANOVA; p Ͻ 0.002) but has no effect on the density of cytisine-sensitive sites ( p Ͼ 0.6). Because most cytisine-resistant [ 125 I]epibatidine binding sites in mouse striatum are sensitive to inhibition by ␣-conotoxin MII (Whiteaker et al., 2000a) , this result is consistent with the selective loss of ␣-conotoxin MII binding sites (Fig. 4 A) Kaiser et al., 1998; Nayak et al., 2001; Grady et al., 2002) . We anticipated, therefore, that the loss of this toxin-sensitive subtype (as indicated by the loss of (Fig. 6 B) Ϫ/Ϫ mice compared with the ␤3 ϩ/ϩ mice. Whether this increase in the ␣-conotoxin MII-resistant dopamine release represents the expression of a novel receptor subtype or increased Figure 3 . Effect of ␤3 deletion on expression of remaining neuronal nAChR subunits. In situ hybridization was conducted to examine mRNA expression of neuronal nAChR subunits with deletion of ␤3. Adjacent brain slices were hybridized with riboprobes complementary to ␣2, ␣3, ␣4, ␣5, ␣6, ␣7, ␤2, or ␤4 subunits. Average values obtained from quantitative analysis of in situ hybridization Ϯ SEM are shown for substantia nigra (SN) and ventral tegmental (VTA) areas (n ϭ 3 per genotype; data for ␣2 expression are not shown, because ␣2 hybridization could not be detected above background at this level of the brain). Representative slices are shown for each subunit to illustrate specific labeling at the level of dopaminergic cell bodies in substantia nigra-ventral tegmental areas. No significant differences in mRNA expression between genotypes were detected for any subunit.
function of a subtype already present in striatum remains to be determined. No difference was observed in samples stimulated with 20 mM potassium, indicating that the general responsiveness of the dopamine release process was unaffected by deletion of the ␤3 subunit.
Behavioral analysis
Locomotor activity and prepulse inhibition of acoustic startle are both behavioral tasks that involve dopaminergic pathways (Ralph et al., 2001) and are modulated by nAChRs (Marks et al., 1986; Bullock et al., 1997) . Therefore, these tests were selected to further investigate potential roles of ␤3-containing nAChRs. Locomotor activity, which is initiated in part by dopaminergic transmission in the nigrostriatal pathway and significantly affected after nigrostriatal degeneration in Parkinson's patients (Rinne, 1993) was assessed using the open field arena (Fig. 7A) .
Overall, ␤3
Ϫ/Ϫ mice demonstrated significantly higher levels of activity than ␤3 ϩ/ϩ littermates over the 60 min testing period (repeated measures MANOVA; p Ͻ 0.03), with the largest differences observed during the first 30 min of testing and a decline to wild-type levels by 60 min. These findings suggest that ␤3-containing nAChRs modulate locomotor activity. In another test, the startle response to an acoustic stimulus (acoustic startle) and the inhibition of acoustic startle by administration of a tone before the acoustic stimulus (prepulse inhibition of startle) were examined. Prepulse inhibition of startle has previously been shown to be mediated by mesolimbic dopaminergic pathways (Ralph et al., 2001 ). Deletion of the ␤3 subunit did not affect the acoustic startle response (Fig. 7B) . ␤3 Ϫ/Ϫ mice, however, demonstrated significantly less overall prepulse inhibition of startle (repeated measures MANOVA; p Ͻ 0.05) (Fig. 7C) . The changes observed in locomotor activity and prepulse inhibition of startle in the ␤3 Ϫ/Ϫ mice provide evidence that these behavioral tasks involving dopaminergic pathways are modulated by nAChRs containing the ␤3 subunit.
Discussion
High-affinity ␣-conotoxin MII site contains the ␤3 subunit Our analysis of the ␤3 null mutant mice revealed that the ␤3 subunit is an essential component of ␣-conotoxin MII-sensitive nAChRs on dopaminergic nerve terminals. This finding expands on those of previous immunochemical, lesioning, and gene deletion studies, which demonstrated that high-affinity ␣-conotoxin MII binding sites in rodent brain may be a complex mixture of ␣6␤2* nAChR subtypes, with contributions from ␣4 or ␤3 sub- units, or both (Vailati et al., 2000; Whiteaker et al., 2000c; Champtiaux et al., 2002; Zoli et al., 2002) . Deletion of either the ␤2 (Whiteaker et al., 2000c) or the ␣6 (Champtiaux et al., 2002) subunit in mouse brain resulted in a loss of high-affinity [ 125 I]␣-conotoxin MII binding sites. In addition, ␣-conotoxin MIIsensitive nicotine-stimulated [ 3 H]dopamine release (as well as the ␣-conotoxin MII-resistant component) was abolished in ␤2 null mutant mice (Grady et al., 2002; Whiteaker et al., 2000c) , further implicating the ␤2 subunit in ␣-conotoxin MII-sensitive nAChRs in rodent brain. Finally, denervation induced by the neurotoxins 6-hydroxydopamine and MPTP nearly eliminates ␣-conotoxin MII-sensitive nAChRs in rodent striatum, indicating that this receptor subtype is expressed selectively on striatal dopaminergic neurons Quik et al., 2003) . These reports, together with the data presented in this paper, indicate that ␤3 may assemble with ␣4, ␣6, and ␤2 subunits to form functional ␣-conotoxin MII-sensitive nAChRs in the mouse nigrostriatal pathway. Comparisons between the responses reported here and nAChRs expressed in vitro are difficult, because few studies have reported successful heterologous expression of ␤3-containing nAChRs, and those that have (Kuryatov et al., 2000; McIntosh et al., 2000) did not study the subunit combination(s) of interest here.
Interestingly, although ␣-conotoxin MII binding was nearly abolished at the level of the dopaminergic nerve terminals in striatum of ␤3 Ϫ/Ϫ mice, only a partial decline in binding sites was observed in the dopaminergic cell bodies in substantia nigra. Given the subunit complexity of nAChRs in this pathway (Vailati et al., 2000; Zoli et al., 2002) , it is possible that several populations of ␣-conotoxin MII-sensitive nAChRs are expressed on the cell bodies in substantia nigra and ventral tegmental areas, including a non-␤3-containing ␣-conotoxin MII-sensitive nAChR, whereas in the nerve terminals projecting into striatum, ␤3-containing ␣-conotoxin MII-sensitive nAChRs are expressed almost exclusively.
Effect of ␤3 deletion on ␣6 expression
Because nAChRs that interact with ␣-conotoxin MII in rodent brain have been shown to require both ␤2 and ␣6 nAChR subunits (Champtiaux et al., 2002 : Grady et al., 2002 Zoli et al., 2002) , it is possible that alteration of the expression of these subunits after ␤3 gene disruption may have confounded interpretation of the role of the ␤3 subunit. Alteration of ␣6 expression could have arisen as a consequence of inserting an IRES-tau-lacZ cassette in close proximity to the ␣6 gene (Chrna6 and Chrnb3 in mice are located as a cluster on a region of mouse chromosome 8 (8A2-8A3) that is syntenic with the region of human chromosome 8 (8P11.2-8P11.3) that contains CHRNA6 and CHRNB3. In mice, Chnrb3 is ϳ29,500 bp long and Chrna6 is ϳ10,800 bp long, with ϳ7000 bp intragenic region. The two genes are in opposite orientation with their 3Ј ends in closest proximity. Although ␤3 gene disruption may have resulted in a small (Ͻ10%) decrease in ␣6 mRNA transcription (Fig. 3) , the dramatic changes in receptor expression observed for ␤3 Ϫ/Ϫ mice are unlikely to result from this putative, comparatively minor change in ␣6 mRNA expression.
Some residual labeling of ␤3 mRNA was observed in in situ hybridization experiments using the full-length mouse ␤3 cDNA probe. The lack of any specific labeling of ␤3 mRNA with the probe complementary to the downstream of the IRES-tau-LacZneo r cassette insertion site demonstrates the disruption of the ␤3 gene. The residual labeling observed with the full-length ␤3 probe is attributable to the detection of the region upstream of the cassette insertion site. We do not expect that translation of this upstream region would produce any ␤3 protein capable of assembling into nAChRs, because it only encodes the sequence before the first transmembrane domain. Additionally, the insertion cassette contains an SV40 polyadenylation signal (Mombaerts et al., 1996) , which prevents the translation of the remainder of the ␤3 gene.
Presynaptic ␤3 nAChRs modulate dopamine release Our data also demonstrate that the ␤3 subunit is an integral component of a subtype of nAChRs that normally modulates dopaminergic neurotransmission in the nigrostriatal pathway. Approximately 30% of nicotine-stimulated dopamine release is mediated by ␣-conotoxin MII-sensitive nAChRs in wild-type mice (Kulak et al., 1997; Kaiser et al., 1998; Nayak et al., 2001; Grady et al., 2002) . Although the ␣-conotoxin MII-sensitive population of nAChRs is virtually eliminated in ␤3 Ϫ/Ϫ mice, there is a corresponding increase in the function of the ␣-conotoxin MIIresistant population. As a result, overall nicotine-stimulated ϩ/ϩ by one-way ANOVA followed by LSD post hoc test (n ϭ 5-7). C, Total nicotinestimulated [ 3 H]dopamine release. *p Ͻ 0.05 different from ␤3 ϩ/ϩ by one-way ANOVA followed by LSD post hoc test (n ϭ 5-7). Genotype had no effect on release stimulated by 20 mM potassium, nor did ␣-conotoxin MII treatment affect baseline release or potassium-stimulated controls (data not shown).
gesting enhanced striatal dopaminergic transmission after cholinergic stimulation. The loss of the ␣-conotoxin MII-sensitive population may have further ramifications, because the agonist affinity for the remaining ␣-conotoxin MII-resistant population is considerably lower (sixfold) (Fig. 6 ) than for the ␣-conotoxin MIIsensitive subtype lost with deletion of the ␤3 subunit. The increased overall function is not matched by a measurable increase in nicotinic binding sites, perhaps suggesting that the remaining receptors are coupled more effectively to dopamine release. Although unexpected, this physiological compensation in ␤3 Ϫ/Ϫ mice subunit does not negate the demonstration that ␤3-containing nAChRs normally mediate a component of this response.
Behavioral effects of ␤3 deletion
Deletion of the ␤3 nAChR subunit had significant behavioral effects. ␤3 null mutant mice displayed increased activity in the open field arena and decreased prepulse inhibition of acoustic startle response. Given that deletion of the ␤3 subunit altered nAChR-mediated dopamine release, it is tempting to ascribe the changes in behavior to the changes in dopaminergic function. Indeed, a large body of evidence implicates dopaminergic systems in the regulation of locomotion (for review, see Jaber et al., 1996) , including the observation that deletion of the dopamine transporter (and thereby hyperdopaminergic activity attributable to increased presence of dopamine extracellularly) increases locomotor activity (Giros et al., 1996) . It would be premature, however, to conclude that the increase in locomotor activity is a direct result of altered dopaminergic activity as a consequence of deletion of the ␤3 subunit. Locomotor activity in the open field is a combination of exploration and anxiety and is influenced by many factors, including but not limited to lighting, apparatus size, previous experience of the mouse in the apparatus, hunger, and thirst (Kelley et al., 1996) . Indeed, the activity that a rat or mouse exhibits in a test box is influenced by as many as 10 genes (Flint et al., 1995) . In contrast, prepulse inhibition of acoustic startle response appears to be a less complex behavior that is also modulated by dopaminergic systems; the response is disrupted by dopaminergic agonists and enhanced by dopaminergic antagonists . The fact that deletion of the ␤3 subunit altered two independent behaviors thought to be mediated by dopaminergic systems is consistent with the proposal that alterations of dopaminergic systems observed in the null mutants underlie these changed responses. Nevertheless, alternative explanations for the effect of ␤3 subunit deletion on these behaviors are clearly possible.
Conclusions
The data presented here demonstrate that many of the ␣-conotoxin MII-sensitive nAChRs expressed on substantia nigra-ventral tegmental area dopaminergic neurons are ␤3 dependent. In turn, these ␤3-containing nAChRs have a physiologically significant role in dopaminergic neurotransmission. Furthermore, locomotor activity and prepulse inhibition of startle, both mediated at least in part by dopaminergic pathways, were altered after ␤3 subunit deletion. This suggests a potential role for ␤3-containing nAChRs in the modulation of these behaviors. Ϫ/Ϫ mice demonstrated significantly higher levels of activity than ␤3 ϩ/ϩ littermates over the testing period (repeated measures ANOVA; *p Ͻ 0.03; Bonferroni post hoc test) (n ϭ 3-6). Acoustic startle response ( B) and prepulse inhibition of startle ( C) were tested during the same session. Although acoustic startle was unaffected by genotype, ␤3 Ϫ/Ϫ mice displayed significantly less prepulse inhibition of startle than ␤3 ϩ/ϩ littermates (repeated measures MANOVA; *p Ͻ 0.05) (n: ␤3 ϩ/ϩ ϭ 38, ␤3 ϩ/Ϫ ϭ 51, ␤3 Ϫ/Ϫ ϭ 25).
